Overview
Zhiwei Peng practices practicing medicine in Nanchang, China.
Peng is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Lymphomatoid Granulomatosis, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Gastrointestinal Stromal Tumor.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Zhiwei Peng
Is Zhiwei Peng a top-rated expert for Lymphomatoid Granulomatosis?
MediFind is an objective health platform that identifies experts based on real-world data. Zhiwei Peng is classified as an Advanced expert for Lymphomatoid Granulomatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Zhiwei Peng participate in research or clinical trials?
Yes. Zhiwei Peng has published 12 articles and abstracts on conditions like Lymphomatoid Granulomatosis. You can view a list of Zhiwei Peng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lymphomatoid Granulomatosis
- Experienced
- Gastrointestinal Stromal Tumor
- Lung AdenocarcinomaPeng isExperienced. Learn about Lung Adenocarcinoma.
- Squamous Cell Lung Carcinoma